MEA Animal Sourced Squalene Market

The size of the Middle East and Africa Animal Sourced Squalene Market is estimated to witness a sluggish growth rate from 2022 to 2027.

The most important characteristic is that Squalene is a natural skin element, as it is found in trace amounts in the skin. As a result, it has several beneficial properties, including anti-oxidation, anti-aging, UV protection, and so on, and is used in the cosmetic, pharmaceutical, and food industries.

The expansion of the cosmetics and pharmaceuticals industries and growing knowledge of squalene's health advantages are driving the market for squalene. Growing R&D on oncology and increased spending on oncology medications are expected to drive the market for squalene during the forecast period in this region. Another important factor is that orphan drugs are expected to generate more significant pharmaceutical revenues by 2025. Oncology pharmaceutical spending is predicted to rise by 6% to 8% over the next five years, boosting the squalene market.

Orphan drugs are expected to generate more significant pharmaceutical revenues by 2025. Oncology pharmaceutical spending is predicted to rise by 6% to 8% over the next five years, boosting the squalene market. Due to increased consumer awareness of the value of using high-quality items and a willingness to pay a premium for them, squalene is in high demand in cosmetics across the Middle East and Africa. Increasing awareness of the dangers of sun exposure is another reason driving the rise of the squalene market in the skincare sector.

However, the progress of the MEA market is expected to be limited by a shortage of trained specialists for training in rural areas and strict government restrictions. Furthermore, appropriate food supplements and nutrition are insufficient to address the demands of the poor and needy in far-flung regions.

This research report on the MEA animal-sourced squalene market has been segmented and sub-segmented into the following categories.

By Application:

• Cosmetics
  • Skin Care
  • Hair Care
  • Fragrance
• Food Supplements
• Healthcare
  • Cancer Treatment
  • Heart Disease
  • Skin Health

By Country:

• KSA
• UAE
• Israel
• rest of GCC countries
• South Africa
• Ethiopia
• Kenya
• Egypt
• Sudan
• rest of MEA

Geographically, the Middle East and Africa account for a moderate portion of the worldwide market in 2020, and the pharmaceutical market is expected to impact future squalene demand significantly. The Middle East and North Africa region is the most enticing market for squalene, with the UAE and Kuwait accounting for most of the chemical's use. Olive oil-based squalene is developing at a lucrative rate in the UAE, thanks to increased demand from regional markets.

In countries like the UAE and Kuwait, personal care and cosmetics, pharmaceuticals, and functional meals are popular. Squalene from shark oil has been outlawed in MEA, forcing manufacturers to transition to plant-based alternatives, including amaranth oil, olive oil, rice bran oil, and others.

KEY MARKET PLAYERS:

A few of the major companies in the MEA animal-sourced squalene market included in this report are  Empressa Figueirrense de Pesca, Arista Industries Inc., Gracefruit Limited, Amyris Inc., Croda International PLC, New Zealand Green Health Ltd., Kishimoto Special Liver Oil Co. Ltd., Maruha Nichiro Corporation, Seadragon Marine Oils Limited, and Arista Industries Inc.